UnitedHealth Group reported a decline in Q3 adjusted earnings and lowered full-year guidance due to COVID-19 related challenges. While the company highlights strong liquidity and strategic initiatives to navigate the pandemic, the negative earnings and cautious outlook are likely to weigh on investor sentiment in the short term.

[-1]